Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical ...

Compass will now seek approval for COMP360, which could become the first classic psychedelic to gain the FDA’s blessing.

Psychedelics can quiet the brain’s visual input system, pushing it to replace missing details with vivid fragments from ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the ...

A psychedelic compound found in the Amazonian hallucinogenic brew ayahuasca quickly curbed clinical depression sufferers’ ...

Compass Pathways (CMPS) added ~20% in the premarket on Tuesday after the U.K.-based biotech announced that its psychedelic ...

Researchers reported rapid, significant improvement in depression, with the benefits lasting for months after treatment.

Helus Pharma (HELP) added ~11% on Tuesday after Nature Medicine published data from a mid-stage trial for SPL026, an ...

Over the last few years, evidence has piled up that psychedelic drugs can provide relatively rapid relief from the symptoms ...

In a small clinical trial, a single dose of a psychedelic drug paired with psychotherapy produced rapid antidepressant ...

The psychedelic DMT has been linked to improved mental health outcomes before, but now, scientists have shown it reduces depression symptoms more than a placebo when given alongside therapeutic suppor ...

The right counselor can make a huge difference.